Consolidated Balance Sheet - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 55	$ 2,150
Receivables, Net, Current	1,398	1,655
Inventories	274	274
Derivative assets	218	239
Other current assets and deferred charges	170	195
Total current assets	2,115	4,513
Investments	4,612	4,637
Property, Plant and Equipment, Gross	54,930	51,842
Accumulated depreciation and amortization	(18,228)	(17,531)
Property, plant, and equipment - net	36,702	34,311
Intangible assets – net of accumulated amortization	7,402	7,593
Regulatory assets, deferred charges, and other	1,578	1,573
Total assets	52,409	52,627
Current liabilities:
Accounts payable	1,192	1,379
Derivative Liability, Current	109	105
Accrued and other current liabilities	1,229	1,284
Commercial Paper	630	725
Long-term debt due within one year	1,536	2,337
Total current liabilities	4,696	5,830
Long-term debt	24,096	23,376
Deferred income tax liabilities	4,107	3,846
Regulatory liabilities, deferred income, and other	4,764	4,684
Contingent liabilities and commitments (Note 9)
Stockholders’ equity:
Preferred stock ($1 par value; 30 million shares authorized at June 30, 2024 and December 31, 2023; 35 thousand shares issued at June 30, 2024 and December 31, 2023)	35	35
Common stock ($1 par value; 1,470 million shares authorized at June 30, 2024 and December 31, 2023; 1,258 million shares issued at June 30, 2024 and 1,256 million shares issued at December 31, 2023)	1,258	1,256
Capital in excess of par value	24,589	24,578
Retained deficit	(12,419)	(12,287)
Accumulated other comprehensive income (loss)	13	0
Treasury stock, at cost (39 million shares at June 30, 2024 and December 31, 2023 of common stock)	(1,180)	(1,180)
Total stockholders’ equity	12,296	12,402
Noncontrolling interests in consolidated subsidiaries	2,450	2,489
Total equity	14,746	14,891
Total liabilities and equity	$ 52,409	$ 52,627